Accepted at 12:14 a.m. Nov, 01, 2023 by dollajas
Author: salamander23
Related Note: 1514738701137
Rationale for change

Changed "Ombitasavir" to "Ombitasvir"

Extra Extra
Text
HCV therapeutics with the suffix {{c1::-asvir}} work by inhibiting the NS5A protein, which plays an integral role in viral {{c2::replication}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy


Sketchy 2
Empty field
Picmonic
Empty field
Pixorize

Physeo




OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::^Systems::GI::pharm #AK_Original_Decks::Step_1::Zanki_Pharmacology !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Bootcamp::Microbiology::39_Antivirals::10_Hepatitis_C_Antiviral_Therapy #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::07_Other_Antivirals::02_Hepatitis_C_Direct-Acting_Antivirals_(DAAs) #AK_Step1_v12::#UWorld::COMLEX::26120 #AK_Step1_v12::#Pixorize::04_Microbiology::03_Antivirals::11_NS5A_Inhibitors #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_3::Viruses::Antiviral_Medications #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::54_Hepatitis_C_Therapy !AK_UpdateTags::AnKing_Image::MS::HCV_management #AK_Step1_v12::#Physeo::06_Micro::05_Viruses::16_Hepatitus_C_Virus #AK_Step1_v12::^Other::^HighYield::4-LowerYield !AK_UpdateTags::AnKing_Image::Mujeeb::HCV_management !AK_UpdateTags::^temporary::ImageFix::20::done #AK_Step1_v12::#UWorld::Step::15144 #AK_Step1_v12::#FirstAid::05_Pharmacology::04_Misc::01_Drug_names #AK_Step1_v12::#Bootcamp::Microbiology::28_Positive-sense_RNA_Viruses::14_Hepatitis_C_Part_2_(Diagnostics_and_Management) !AK_UpdateTags::AnKing_Image::Rebecca #AK_Step1_v12::#Physeo::09_Pharm::02_Antivirals::10_Hepatitis_C_Therapy #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::08_Retired_Lessons::04_Ribavirin,_Sofosbuvir,_Simeprevir_[Retired_Video]